Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance.
- NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_assertion description "[The expression of SDC- 1, fibroblast growth factor 2 (FGF-2), and FGF receptor 1 (FGFRI) and their transcripts in 65 samples including the normal ovary, benign tumors, borderline ovarian tumors, and EOC was assessed using immunohistochemistry and the reverse transcription-polymerase chain reaction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance.
- NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_assertion evidence source_evidence_literature NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance.
- NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_assertion SIO_000772 26513873 NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance.
- NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_assertion wasDerivedFrom befree-2016 NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance.
- NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_assertion wasGeneratedBy ECO_0000203 NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance.
- befree-2016 importedOn "2016-02-19" NP1295300.RAZp7lNI7MxLcToUEV90V3_3lLfJRzEbBSo5Bd_UUkCCA130_provenance.